DEVIT vs EXPLEOSOL: Stock Comparison

DEV INFO TECHNOLOGY vs EXPLEO SOLUTIONSUpdated 11 Sept 26, 4:08 PM ISTNSE & company filings

EXPLEO SOLUTIONS is the larger company by market capitalisation. DEV INFO TECHNOLOGY shows a lower P/E, a higher ROE and a higher ROCE, while EXPLEO SOLUTIONS shows a higher dividend yield, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

DEVIT leads 7; EXPLEOSOL leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

DEVITEXPLEOSOL

Valuation lens

What price are you paying?

Market CapContext only
₹137 Cr
₹1,383 Cr
P/E RatioDEVIT has the lower reading
2.35x
10.02x
P/B RatioDEVIT has the lower reading
1.24x
1.78x
EPSEXPLEOSOL has the higher reading
₹0.23
₹18.78
Book ValueContext only
₹19.39
₹500.21
Dividend YieldEXPLEOSOL has the higher reading
0.41%
12.34%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
EXPLEOSOL is the larger company
₹1,383 Cr vs ₹137 Cr
P/E Ratio
DEVIT has a lower P/E
2.35x vs 10.02x
P/B Ratio
DEVIT has a lower P/B
1.24x vs 1.78x
EPS
EXPLEOSOL has higher earnings per share
₹18.78 vs ₹0.23
Dividend Yield
EXPLEOSOL has a higher dividend yield
12.34% vs 0.41%
Revenue Growth (TTM YoY)
EXPLEOSOL has faster revenue growth
11.9% vs 4.5%
EPS Growth (TTM YoY)
DEVIT has faster EPS growth
632.1% vs 73.2%
Qtr Sales Growth
EXPLEOSOL has stronger quarterly sales growth
-12.31% vs -26.36%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricDEVITEXPLEOSOL
SectorInformation TechnologyInformation Technology
IndustryIT Enabled ServicesIT Enabled Services

Price

MetricDEVITEXPLEOSOL
Live Price₹24.18₹889.5
Day Change0.88%0.64%
Volume37,8649,546
52-Week High₹45₹1,175.1
52-Week Low₹22.25₹640
Distance from 52W High-46.27%-24.3%

Valuation

MetricDEVITEXPLEOSOL
Market Cap₹137 Cr₹1,383 Cr
P/E Ratio2.35x10.02x
P/B Ratio1.24x1.78x
EPS₹0.23₹18.78
Book Value₹19.39₹500.21
Dividend Yield0.41%12.34%

Growth

MetricDEVITEXPLEOSOL
Revenue Growth (TTM YoY)4.5%11.9%
EPS Growth (TTM YoY)632.1%73.2%
Qtr Sales Growth-26.36%-12.31%
Qtr Profit Growth-38%-14.75%

Profitability & Leverage

MetricDEVITEXPLEOSOL
ROE67.3%15.97%
ROCE73.37%31.98%
Net Margin39.99%11.19%
Operating Margin58.92%14.87%
Debt to Equity0.22x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricDEVITEXPLEOSOL
Promoter Holding37.81%71.05%
FII Holding0.33%0.13% 0.29 pp
DII Holding0%0.12% 0.11 pp
Public Holding58.09%28.7% 0.17 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: DEV INFO TECHNOLOGY and EXPLEO SOLUTIONS.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.